- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 132,240 | 26.06.24 20:32:14 | -0,680 | -0,51% | 132,230 | 132,250 | 133,140 | 132,920 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 78,290 | 26.06.24 20:24:48 | -0,610 | -0,77% | 78,020 | 78,300 | 78,450 | 78,900 |
